A functional missense variant in MRI1 links methionine salvage to reduced type 2 diabetes risk.

Authors

Khushdeep Bandesh, Michael Traurig, Kendrick Freeland, Paolo Piaggi, Leslie J Baier

Published in

iScience. Volume 29. Issue 9. Pages 117243. Sep 18, 2026. Epub Aug 20, 2026.

Abstract

Type 2 diabetes (T2D) pathogenesis is shaped by both risk and protective genetic variants, but mechanisms underlying disease protection remain understudied. Previously, in a population isolate with high T2D prevalence, we unexpectedly identified a relatively frequent protective missense variant (Arg149Cys, rs551664067 C/T) in the methionine salvage gene MRI1, never reported for T2D. MRI1 is expressed in human pancreatic islets and insulin-responsive tissues, with islet expression correlating with insulin expression. Using MRI1's resolved crystal structure, we show Arg149Cys substitution compacts the ligand-binding pocket by >53%, and enzyme kinetics confirm enhanced substrate engagement and 18.6% improved catalytic flux, boosting methionine salvage for downstream pathway enzymes. Circulating methionine levels inversely correlated with insulin sensitivity, consistent with enhanced MRI1 activity channeling methionine into salvage rather than pathological accumulation. Together, MRI1 is identified as a metabolic regulator that links enzyme biophysics to efficient methionine recycling and T2D protection, showcasing quantitative NMR as a genetics-to-mechanism bridge.

PMID:
42667062
Bibliographic data and abstract were imported from PubMed on 29 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.